Name: Songlin Peng

Academic qualifications:

1997-2002  B. Med.     Three Gorges University School of Medicine, Yichang, China

2002-2008  M.D.          Department of Orthopaedic Surgery, Tongji Medical School,

                                Huazhong University of Science and Technology, Wuhan, China

2008-2011  Ph.D.         Department of Orthopaedics & Traumatology,

                                The University of Hong Kong  

Previous academic positions held:

2002-2005  Residency                 Department of Orthopedic Surgery, Tongji Medical School,

                                              Huazhong University of Science and Technology,

                                              Wuhan,China

2008-2009  Research Fellowship    Bone Bioengineering Lab, Department of Biomedical

                                              Engineering,Columbia University, USA

Present academic position:

2011-   Assistant Professor              Department of SpineSurgery, Shenzhen People’s

                                                  Hospital, Jinan University Second Medical College,

                                                  Shenzhen, China

2011-   Post doctoral Clinical Fellow  Institute for Advancing Translational Medicine in Bone &

                                                  Joint Diseases, Hong Kong Baptist University, Hong Kong

Previous relevant research work:

Technical expertise   Bone biology, Bone histomorphometry  

Research area          R&D of novel anabolic agents for prevention and treatment of

                             osteoporosis; Stem cells regeneration inage-related bone and cartilage

                             disorders (postmenopausal osteoporosis and disc degeneration)

Publications (Representative peer-reviewjournal publications in recent years):  

 1.  Peng S, Zhang G, Zhang BT, Guo B, He Y, Bakker BJ, Pan X, Zhen W, Hung L, Qin L,Leung

      WN. The Beneficial Effect of Icaritin on Osteoporotic Bone is Dependenton the Treatment

      Initiation Timing in Adult Ovariectomized Rats.  Bone 2013; 55(1):230-40.

 2.  Peng S, Pan H, Lu WW Osteoprotegerin plays a key role in the dual action ofstrontium on

      bone remodeling: Evidences from bench to clinic.Bone 2012, 50:1203-1204.

 3.  Peng S, Liu XS, Huang S,Li Z, Pan H, Zhen W, Luk KD, Guo XE, Lu WW. The Cross-talk

      Between Osteoclastsand Osteoblasts in Response to Strontium Treatment: Involvement of

      Osteoprotegerin. Bone 2011 Dec;49(6):1290-8.

 4.  Peng S, Liu XS, Zhou G,Li Z, Luk KD, Guo XE, Lu WW. Osteoprogeterin deficiency

      attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption

       JBone Miner Res 2011,2011 Jun;26(6):1272-82.

 5.  Peng S, Liu XS, Wang T,Li Z, Zhou G, Luk KD, Guo XE, Lu WW. In vivo anabolic effect of

      strontium on trabecular bone was associated with increased osteoblastogenesis of bone

      marrow stromal cells. J Orthop Res 2010; 28:1208-1214.

 6.  Peng S, Zhang G, He Y, Wang X, Leung P, Leung K, Qing L.Epimedium-derived flavonoids

      promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while

      exerting an anabolic effect on osteoporotic bone.Bone 2009;45:534-544